Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Liked2Thinkon Apr 02, 2021 10:51pm
355 Views
Post# 32933164

Whichever side you are on

Whichever side you are onbasher or pumper or stuck in the middle there is no denying yesterday was a collosal F up on part of the company and specifically Tripp.

Yes it might be great in the end and it could be a great plan but just think where would the stock price be today if they had just released the financial information only.

Release finanaicals with a tid bit of Aristotle active this Monday.  Would had been great.

The health clinic thing they were not prepared for and it shows.

They knew they were going to release this info a week ago.  why not have a trial run through internally.  Why would they release this kind of news before releasing good financial data.  Yes I know there was a "glitch" but isnt there always a glitch every quarter it seems.

Imagine if they had only released financials and then bam monday or tuesday release the health clinc stuff.

Im not smarter than Tripp or likely anyone else that works for Stage but this stuff just seems like common sense.

I am positive we would be at 2 bucks right now and with the extra news on monday or tuesday maybe 2.15-2.20 and have all kinds of momentum with our principle product

instead most of the stockholders are pi$$ed off.  Hopefully Tripp called the guy that was asking the first questions and walked him through everything cause that was the most paintful thing ive ever heard
<< Previous
Bullboard Posts
Next >>